MINUTES
About Minutes
Back to latest

HealthSellas vaccine extends survival in blood cancer trial, shares surge

Drug developer Sellas Life Sciences said on Tuesday that its experimental vaccine for a type of blood cancer significantly prolonged patients’ lives in a late-stage trial, triggering a record one-day jump in its shares.

cancervaccineclinical trial

RReuters★★☆☆☆2026-11-17 15:10Original

Sellas vaccine extends survival in blood cancer trial, shares surge
Sellas vaccine extends survival in blood cancer trial, shares surgeHealth